Clovis Oncology to Present at the BofA Securities 2022 Healthcare Conference
05 Maggio 2022 - 2:00PM
Business Wire
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its
President and Chief Executive Officer, Patrick J. Mahaffy, will
present at the BofA Securities 2022 Healthcare Conference on
Wednesday, May 11, 2022, at 10:00 a.m. Pacific time. The conference
will be held at the Encore hotel in Las Vegas.
A live webcast of the presentation can be accessed through the
investor relations section of the Company’s website at
www.clovisoncology.com. Following the live presentation, a replay
of the webcast will be available on the Company’s website for 30
days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the US, Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops, with partners,
diagnostic tools intended to direct a compound in development to
the population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado; please visit
www.clovisoncology.com for more information, including additional
office locations in the US and Europe.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220505005142/en/
Anna Sussman (303) 625-5022 asussman@clovisoncology.com
Breanna Burkart (303) 625-5023 bburkart@clovisoncology.com
Grafico Azioni Clovis Oncology (NASDAQ:CLVS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Clovis Oncology (NASDAQ:CLVS)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Clovis Oncology Inc (NASDAQ): 0 articoli recenti
Più Clovis Oncology, Inc. Articoli Notizie